Rozglyn MP 2mg/500mg/15mg Tablet
Marketer
Bilberry Pharmaceutical Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Rozglyn MP 2mg/500mg/15mg Tablet
GlycoBalance Trio 2mg/500mg/15mg tablets combine ingredients to manage blood glucose. This medication, used alongside diet and exercise, improves blood sugar control in adults with type 2 diabetes. It enhances insulin effectiveness, reducing blood sugar. Follow your doctor's prescribed dosage and frequency, taking it with food to prevent digestive upset. If a dose is missed, take it promptly unless the next dose is imminent; avoid doubling up. An overdose can cause dangerously low blood sugar (hypoglycemia). Hypoglycemia is a potential risk, particularly when combined with other diabetes medications, alcohol, or missed meals. Regular blood sugar monitoring is vital. Common side effects may include nausea, diarrhea, abdominal discomfort, headache, bone fractures, and respiratory infections. Inform your physician of any kidney, liver, or heart conditions before starting treatment. Pregnant or nursing individuals should seek medical advice. Kidney function tests will be assessed prior to commencing therapy. Limit alcohol consumption, as it may heighten the risk of side effects.
Primary Ingredients of Rozglyn MP 2mg/500mg/15mg Tablet
No text was provided. Please provide the text you wish me to rewrite.
Uses of Rozglyn MP 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Rozglyn MP 2mg/500mg/15mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Rozglyn MP 2mg/500mg/15mg tablets with a meal.
Common Side effects of Rozglyn MP 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Rozglyn MP 2mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Rozglyn MP 2mg/500mg/15mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.
How Rozglyn MP 2mg/500mg/15mg Tablet works:
Rozglyn MP tablets (2mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thereby reducing blood glucose levels. Metformin, a biguanide, acts via multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Rozglyn MP 2mg/500mg/15mg Tablet with alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Rozglyn MP 2mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Employing Rozglyn MP 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Rozglyn MP 2mg/500mg/15mg tablets, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in individuals with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Rozglyn MP 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Rozglyn MP 2mg/500mg/15mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Rozglyn MP 2mg/500mg/15mg Tablet :
Should you forget a Rozglyn MP 2mg/500mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rozglyn MP 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently